The ELIXIR Rare Disease (RD) Community will continue to be committed to the International Rare Disease Research Consortium (IRDiRC) Vision for 2027: Enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention.

To support such vision and facilitate data interoperability and analysis, the Community drives the assembly of service collections relevant for RD research, seeks interactions with other ELIXIR Human Data Communities to adapt and integrate resources and conducts Proof of Concept and pilot implementations of standards and methodologies.

These desired goals will be delivered through work across four work-packages that collectively focus on the following objectives:

• Coordinate and align RD research activities related to data resources, tools and services within ELIXIR and with other European and International activities

• Demonstrate the exploitation of FAIR data to reduce analytics complexity for data scientists

• Consolidate the recently created ELIXIR RD Service Collections (former “Bundles”)

• Disseminate and provide training on services and developments from the ELIXIR RD Community in collaboration with the ELIXIR Training Platform

The present study is participated in by eleven ELIXIR Nodes: ELIXIR Belgium (Tom Lenaerts), ELIXIR Spain, ELIXIR Germany, ELIXIR Italy, ELIXIR France, ELIXIR Greece, ELIXIR Luxembourg, ELIXIR Slovenia, ELIXIR The Netherlands, ELIXIR Switzerland, and ELIXIR UK.